Whitehawk Therapeutics Inc

NASDAQ:WHWK

Biotechnology

Healthcare
$3.12 +1.42%

+$0.06 today

Market cap
$184.11M
Beta
0.77
P/E (TTM)
-2.6
EPS (TTM)
-$1.67
52W Low $1.57High $5.50

Volume 0.40M

Average 0.31M

Income Statement

Follow revenue through to earnings.

Revenue

$7.14M

FY 2025 · Annual

-72.5% YoY

Operating Income

-$114.40M

FY 2025 · Annual

Net Income

-$20.60M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.12M15.22M24.35M25.98M7.15M
Cost of Revenue19.67M34M51.74M54.05M760K
Gross Profit(18.55M)(18.78M)(27.38M)(28.07M)6.39M
Gross Margin-1656.3%-123.4%-112.4%-108.0%89.4%
Research & Development19.67M32.66M48.93M51.03M90.96M
Selling, General & Admin18.51M40.18M44.55M36.75M29.82M
Operating Expenses92.67M43.9M44.55M39.39M120.79M
Depreciation & Amortization105K159K169K193K79K
EBITDA(36.96M)(58.8M)(65.37M)(64.63M)(20.52M)
EBITDA Margin-3299.6%-386.4%-268.4%-248.7%-287.2%
Operating Income(111.22M)(62.68M)(71.93M)(67.46M)(114.4M)
Operating Margin-9930.1%-411.9%-295.4%-259.6%-1601.1%
Interest Income13K2.4M6.4M3.93M6.23M
Interest Expense665K230K231K154K0
Other Income / Expenses1.13M2.17M6.17M3.77M93.8M
Income Before Tax(110.09M)(60.51M)(65.77M)(63.69M)(20.6M)
Pre-Tax Margin-9829.3%-397.7%-270.0%-245.1%-288.3%
Income Tax Expense2K0000
Net Income(110.09M)(60.51M)(65.77M)(63.69M)(20.6M)
Net Margin-9829.5%-397.7%-270.0%-245.1%-288.3%
EPS (Basic)(12.41)(2.69)(2.44)(2.36)(0.33)
EPS (Diluted)(12.41)(2.69)(2.44)(2.36)(0.33)
Weighted Avg Shares8.87M22.51M26.92M27.03M61.89M
Weighted Avg Shares (Diluted)8.92M22.51M26.92M27.03M61.89M

WHWK Earnings Waterfall · TTM

NASDAQ:WHWK · Revenue to Net Income

Key Ratios

EPS$-1.68
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-1.7
P/S Ratio0.0

Analysis

$0 of revenue converted into -$115.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.68, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
DEFA14ADEFA14A filingApr 28, 2026
ARSARS filingApr 28, 2026

How much revenue does WHWK generate?

Whitehawk Therapeutics Inc (WHWK) reported $7.14M of revenue in fiscal 2025.

Is WHWK profitable?

Whitehawk Therapeutics Inc (WHWK) reported -$20.60M of net income, with a net margin of -288.3%.